News
Lucem Health Featured in Yahoo Finance Coverage of iRhythm’s Growth Strategy
Yahoo Finance mentions Lucem Health–iRhythm partnership that accelerates early arrhythmia detection and data-driven care.
Sean Cassidy Featured in Patient Safety & Quality Healthcare (PSQH)
PSQH feature: Our CEO explains how the new federal spending law pressures health systems to act fast on costs, Medicaid, and service-line strategy.
Lucem Health announces new initiative to accelerate early detection of Type 1 Diabetes (T1D)
Lucem Health launches Reveal for T1D, using AI and EHR data to identify early-stage T1D, backed by Sanofi to improve diagnosis and outcomes.
Lucem Health Featured in Charlotte Business Journal
Lucem Health featured in Charlotte Business Journal—raised $2.3M to advance AI disease detection and expand its team over the next year.
Lucem Health and iRhythm Announce Strategic Partnership for Early Arrhythmia Detection
Learn how Lucem Health and iRhythm are joining forces to deliver earlier arrhythmia detection, improving lives and reshaping cardiac care.
Lucem Health Launches Reveal for Lung Cancer, A New AI-Driven Solution to Accelerate Lung Cancer Screening for At-Risk Patients
Reveal for Lung Cancer analyzes existing EHR data to identify patients who show a higher statistical risk of certain respiratory illnesses, including cancers of the lung or trachea.
Lucem Health Listed in Top 10 AI Titans 2024
Lucem Health featured as one of the "Top 10 AI Titans Empowering Family Offices in the Age of AI: Investment Trends and Opportunities".
Lucem Health Introduces Reveal for Stroke to Accelerate Treatment of AFib-Related Stroke Risks
Introducing Reveal for Stroke, designed to identify patients with undiagnosed AFib and higher risk of AFib-related strokes.
HIStalk Interview with Sean Cassidy, CEO of Lucem Health
Our CEO, Sean Cassidy, was recently interviewed by HIStalk on the difficulties for health systems integrating AI, helping health system executives develop a plan for AI, the nuance between AI models and AI solutions, and more.
